31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Tang FR, Bradford HF, Ling EA. Metabotropic glutamate receptors in the control of neuronal activity and as targets for development of anti-epileptogenic drugs. Current Medicinal Chemistry. 16: 2189-204. PMID 19519386 DOI: 10.2174/092986709788612710  0.466
1998 Abdul-Ghani AS, Attwell PJ, Bradford HF. The effect of 2-amino-3-arsonopropionate and 2-amino-4-arsonobutyrate on the development and maintenance of amygdala kindled seizures. The International Journal of Neuroscience. 96: 255-67. PMID 10069625  0.557
1998 Attwell PJ, Singh Kent N, Jane DE, Croucher MJ, Bradford HF. Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2'R, 3'R)-2-(2',3'-dicarboxycyclopropyl)glycine (DCG-IV). Brain Research. 805: 138-43. PMID 9733953 DOI: 10.1016/S0006-8993(98)00698-2  0.769
1998 Attwell PJ, Koumentaki A, Abdul-Ghani AS, Croucher MJ, Bradford HF. Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats. Brain Research. 787: 286-91. PMID 9518652 DOI: 10.1016/S0006-8993(97)01500-X  0.716
1997 Abdul-Ghani AS, Attwell PJ, Bradford HF. The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures. European Journal of Pharmacology. 326: 7-14. PMID 9178649 DOI: 10.1016/S0014-2999(97)00139-8  0.527
1997 Abdul-Ghani AS, Attwell PJ, Singh Kent N, Bradford HF, Croucher MJ, Jane DE. Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist. Brain Research. 755: 202-12. PMID 9175888 DOI: 10.1016/S0006-8993(97)00098-X  0.75
1997 Croucher MJ, Ruffle KL, Bradford HF. The effects of focal N-methyl-D-aspartate pretreatment on the parameters of amygdaloid electrical kindling. European Journal of Pharmacology. 319: 207-13. PMID 9042592 DOI: 10.1016/S0014-2999(96)00868-0  0.756
1996 Abdul-Ghani AS, Attwell PJ, Bradford HF. The anti-epileptic effect of 3-aminopropylarsonate on electrically-kindled and N-methyl-D-aspartate-kindled amygdala. Brain Research. 742: 305-12. PMID 9117409 DOI: 10.1016/S0006-8993(96)01032-3  0.584
1996 Croucher MJ, Cotterell KL, Bradford HF. Characterisation of N-methyl-D-aspartate (NMDA)-induced kindling. Biochemical Society Transactions. 24: 295S. PMID 8736953 DOI: 10.1042/Bst024295S  0.67
1996 Bradford HF. Basic neurochemical mechanisms of the epilepsies. Neurotransmitter systems involved International Medical Journal. 3: 175-193.  0.313
1995 Bradford HF. Glutamate, GABA and epilepsy. Progress in Neurobiology. 47: 477-511. PMID 8787032 DOI: 10.1016/0301-0082(95)00030-5  0.549
1995 Croucher MJ, Cotterell KL, Bradford HF. Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling. European Journal of Pharmacology. 286: 265-71. PMID 8608788 DOI: 10.1016/0014-2999(95)00459-6  0.784
1995 Attwell PJ, Kaura S, Sigala G, Bradford HF, Croucher MJ, Jane DE, Watkins JC. Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist. Brain Research. 698: 155-62. PMID 8581475 DOI: 10.1016/0006-8993(95)00886-U  0.73
1995 Kaura S, Bradford HF, Young AM, Croucher MJ, Hughes PD. Effect of amygdaloid kindling on the content and release of amino acids from the amygdaloid complex: in vivo and in vitro studies. Journal of Neurochemistry. 65: 1240-9. PMID 7643103 DOI: 10.1046/J.1471-4159.1995.65031240.X  0.681
1993 Young AM, Bradford HF. N-methyl-D-aspartate releases gamma-aminobutyric acid from rat striatum in vivo: a microdialysis study using a novel preloading method. Journal of Neurochemistry. 60: 487-92. PMID 8093478 DOI: 10.1111/j.1471-4159.1993.tb03176.x  0.406
1993 Kaura S, Croucher MJ, Bradford HF, Sunter DC, Watkins JC. Relative anticonvulsant potencies of CPP and some novel analogues in the kindled rat. Biochemical Society Transactions. 21: 419S. PMID 7907558 DOI: 10.1042/Bst021419S  0.64
1992 Croucher MJ, Cotterell KL, Bradford HF. Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds. Neurochemical Research. 17: 409-13. PMID 1356242 DOI: 10.1007/BF00969885  0.769
1992 Cotterell KL, Croucher MJ, Bradford HF. Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration. European Journal of Pharmacology. 214: 285-7. PMID 1355438 DOI: 10.1016/0014-2999(92)90132-N  0.754
1991 Young AM, Bradford HF. N-methyl-D-aspartate releases excitatory amino acids in rat corpus striatum in vivo. Journal of Neurochemistry. 56: 1677-83. PMID 1826519  0.448
1991 Croucher MJ, Marriott DR, Bradford HF, Wilkin GP. Lack of effect of focally administered prostaglandins on electrically kindled seizure activity. Prostaglandins. 42: 29-38. PMID 1771237 DOI: 10.1016/0090-6980(91)90091-S  0.757
1991 Croucher MJ, Bradford HF. The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds. Brain Research. 543: 91-6. PMID 1647257 DOI: 10.1016/0006-8993(91)91051-2  0.757
1990 Croucher MJ, Bradford HF. 7-Chlorokynurenic acid, a strychnine-insensitive glycine receptor antagonist, inhibits limbic seizure kindling. Neuroscience Letters. 118: 29-32. PMID 2175409 DOI: 10.1016/0304-3940(90)90241-Z  0.776
1990 Croucher MJ, Bradford HF. NMDA receptor blockade inhibits glutamate-induced kindling of the rat amygdala. Brain Research. 506: 349-52. PMID 1967970 DOI: 10.1016/0006-8993(90)91279-P  0.76
1989 Croucher MJ, Bradford HF. Kindling of full limbic seizures by repeated microinjections of excitatory amino acids into the rat amygdala. Brain Research. 501: 58-65. PMID 2572307 DOI: 10.1016/0006-8993(89)91026-3  0.775
1988 Croucher MJ, Bradford HF, Sunter DC, Watkins JC. Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists. European Journal of Pharmacology. 152: 29-38. PMID 3208834 DOI: 10.1016/0014-2999(88)90832-1  0.758
1988 Young AM, Crowder JM, Bradford HF. Potentiation by kainate of excitatory amino acid release in striatum: complementary in vivo and in vitro experiments. Journal of Neurochemistry. 50: 337-45. PMID 2891791  0.395
1987 Bradford HF, Young AM, Crowder JM. Continuous glutamate leakage from brain cells is balanced by compensatory high-affinity reuptake transport. Neuroscience Letters. 81: 296-302. PMID 2893318 DOI: 10.1016/0304-3940(87)90399-5  0.348
1987 Crowder JM, Croucher MJ, Bradford HF, Collins JF. Excitatory amino acid receptors and depolarization-induced Ca2+ influx into hippocampal slices. Journal of Neurochemistry. 48: 1917-24. PMID 2437250 DOI: 10.1111/J.1471-4159.1987.Tb05756.X  0.672
1986 Young AM, Bradford HF. Excitatory amino acid neurotransmitters in the corticostriate pathway: studies using intracerebral microdialysis in vivo. Journal of Neurochemistry. 47: 1399-404. PMID 2876052  0.362
1984 Peterson DW, Collins JF, Bradford HF. Anticonvulsant action of amino acid antagonists against kindled hippocampal seizures. Brain Research. 311: 176-80. PMID 6148999 DOI: 10.1016/0006-8993(84)91414-8  0.516
1983 Peterson DW, Collins JF, Bradford HF. The kindled amygdala model of epilepsy: anticonvulsant action of amino acid antagonists. Brain Research. 275: 169-72. PMID 6138123 DOI: 10.1016/0006-8993(83)90431-6  0.482
Show low-probability matches.